Insider Trading History of Murphy James G

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Murphy James G since 2007. The trader's CIK number is 1286032. At the time of the last reporting, Murphy James G was the Director of Biomimetic Therapeutics, Inc.. (stock ticker symbol BMTI). Also see all insider trading activities at Biomimetic Therapeutics, Inc..

Note that in the past MURPHY JAMES G also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Biomimetic Therapeutics, Inc. (BMTI) by Murphy James G

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 BMTI 0 $0 0 $0 38,736 $163,272
2010 BMTI 0 $0 0 $0 9,720 $35,283
2009 BMTI 508 $4,318 0 $0 0 $0
2008 BMTI 5,000 $42,000 0 $0 0 $0

Yearly summary of insider trading at Immunicon Corp (IMMC) by Murphy James G

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 IMMC 10,000 $31,204 0 $0 0 $0


Insider trading activities at 2 companies by Murphy James G:

1. Biomimetic Therapeutics, Inc. (BMTI)

2. Immunicon Corp (IMMC)

Table 1. Insider trading of Biomimetic Therapeutics, Inc. (BMTI) by Murphy James G

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-03-01 BMTI Option Ex 38,736 4.21 163,272
2010-09-07 BMTI Option Ex 9,720 3.63 35,283
2009-06-25 BMTI Buy 508 8.50 4,318
2008-03-28 BMTI Buy 5,000 8.40 42,000

Table 2. Insider trading of Immunicon Corp (IMMC) by Murphy James G

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-03-21 IMMC Buy 1,000 3.00 3,000
2007-03-14 IMMC Buy 1,000 2.93 2,930
2007-03-07 IMMC Buy 1,000 2.95 2,950
2007-02-28 IMMC Buy 1,000 2.85 2,850
2007-02-14 IMMC Buy 1,000 3.48 3,480
2007-02-07 IMMC Buy 1,000 3.33 3,330
2007-01-31 IMMC Buy 1,000 3.14 3,140
2007-01-24 IMMC Buy 1,000 3.07 3,070
2007-01-17 IMMC Buy 1,000 3.21 3,214
2007-01-10 IMMC Buy 1,000 3.24 3,240

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Murphy James G (Director of Biomimetic Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.